Neuroprotective action of Cortexin, Cerebrolysin and Actovegin in acute or chronic brain ischemia in rats.
This study was the first to compare the neuroprotective activity of Cerebrolysin®, Actovegin® and Cortexin® in rodent models of acute and chronic brain ischemia. The neuroprotective action was evaluated in animals with acute (middle cerebral artery occlusion) or chronic (common carotid artery stenos...
Guardado en:
Autores principales: | Denis V Kurkin, Dmitry A Bakulin, Evgeny I Morkovin, Anna V Kalatanova, Igor E Makarenko, Artem R Dorotenko, Nikolay S Kovalev, Marina A Dubrovina, Dmitry V Verkholyak, Elizaveta E Abrosimova, Alexey V Smirnov, Maksim V Shmidt, Ivan N Tyurenkov |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e345af691eb64e8cace1bedfb00ef977 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
CORTEXIN IN THE PREVENTION OF SYNDROME OF INTRACRANIAL HYPERTENSION AT THE EFFECTS OF CLOSED CRANIOCEREBRAL INJURY
por: T. A. Prokayeva, et al.
Publicado: (2012) -
Nootropic and Adaptogenic Effect of Combined Use of Cortexin with Polyunsaturated Fatty Acids Concentrate under Experimental Dislipidemia
por: Tatyana I. Sangadieva, et al.
Publicado: (2019) -
Cerebrolysin effects on neurological outcomes and cerebral blood flow in acute ischemic stroke
por: Amiri-Nikpour MR, et al.
Publicado: (2014) -
Drug discovery for type 2 diabetes mellitus and metabolic syndrome: ten novel biological targets
por: Ivan Nikolaevich Tyurenkov, et al.
Publicado: (2015) -
Clinical efficacy of oxidative stress correction by actovegin in diabetic polyneuropathy at type 2 diabetic patients with arterial hypertension
por: Ivan Petrovich Gorshkov, et al.
Publicado: (2010)